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Abstract
Background: The Arg-Gly-Asp (RGD) cell adhesion sequence occurs in several extracellular
matrix molecules known to interact with integrin cell-surface receptors. Recently published crystal
structures of the extracellular regions of two integrins in complex with peptides containing or
mimicking the RGD sequence have identified the Arg and Asp residues as key specificity
determinants for integrin recognition, through hydrogen bonding and metal coordination
interactions. The central Gly residue also appears to be in close contact with the integrin surface
in these structures.
Results:  When hydrogen atoms are modelled on the central Gly residue with standard
stereochemistry, the interaction between this residue and a carbonyl group in the integrin surface
shows all the hallmarks of Cα -H···O=C hydrogen bonding, as seen in the collagen triple helix and
in many crystal structures of small organic molecules. Moreover, molecular dynamic simulations of
the docking of RGD-containing fragments on integrin surfaces support the occurrence of these
interactions. There appears to be an array of four weak and conventional hydrogen bonds lining up
the RGD residues with main chain carbonyl groups in the integrin surface.
Conclusions:  The occurrence of weak Cα -H···O=C hydrogen bonds in the RGD-integrin
interaction highlights the importance of the conserved Gly residue in the RGD motif and its
contribution to integrin-ligand binding specificity. Our analysis shows how weak hydrogen bonds
may also play important biological roles by contributing to the specificity of macromolecular
recognition.
Background
The Arg-Gly-Asp (RGD) sequence is one of the most easily
recognised motifs in molecular biology [1]. Discovered in
fibronectin in 1984 [2], this tripeptide appears to be con-
served in the cell attachment sites of many proteins from
the extracellular matrix (ECM). The later discovery that
RGD is recognised by members of the integrin family of
cell surface receptors [3], confirmed the central role of
RGD and suggested that its presence in a protein sequence
might be indicative of cell-adhesion functionality [4].
Integrins are ubiquitously expressed heterodimer cell sur-
face molecules that act as receptors for ECM molecules
and other cell-surface adhesins. Through these cell-matrix
and cell-cell interactions integrins control diverse cell
functions such as adhesion, shape, growth, differentiation
and mobility, and therefore contribute to important phys-
iological processes such as development, immune
responses and cancer [5]. Integrins are complex signalling
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engines: their extracellular domains interact with the ECM
while their cytoplasmic tails interact with the cytoskeleton
and other intracellular signalling molecules. Current
hypotheses suggest that conformational changes resulting
from these interactions enable integrins to transmit sig-
nals across the membrane in both directions. Recent
advances in the structural biology of several integrin
domains and their interactions with ligands have begun
to define possible working scenarios for the signalling
mechanisms [6-13].
As a consequence of their role in so many fundamental
processes, integrin defects have been implicated in many
common diseases, from cancer to pathogen invasion. An
ability to block a particular integrin-ligand interaction
may be a possible route to the control of certain patholog-
ical states, hence it is not surprising that some integrins
have become attractive targets for drug design. Under-
standing the molecular bases of the interaction of
integrins with their ligands is therefore essential for effec-
tive protein-based design of inhibitors or activators of
their function. A milestone was reached in 2002 with the
determination of the crystal structure of the extracellular
segment of α Vβ 3 integrin in complex with a cyclic peptide
containing the prototypical RGD sequence [8]. In that
structure, the amino acids defining the RGD sequence are
seen to establish specific interactions with corresponding
residues in the integrin heterodimer surface, spanning the
interface between the α V and β 3 subunits (Figure 1a).
Very recently, another landmark paper has reported sev-
eral crystal structures of the extracellular region of the
fibrinogen-binding integrin α IIbβ 3 [12]. In addition to
providing an improved picture of the allosteric basis of
integrin signal transmission, this new set of structures
shows the molecular details of the interaction between the
α IIbβ 3 RGD-binding site and various ligand mimetics
(Figure 1b). These interactions are remarkably consistent
with those previously observed in the complex between
the α Vβ 3 integrin fragment and the cyclic RGD peptide
(cRGD) [8].
At first glance, two interactions consistently seen in these
crystal structures appear to be key in defining the specific
molecular recognition between the RGD sequence in an
integrin ligand and the surface of its integrin receptor: the
Asp residue of the RGD triad completes the coordination
of a divalent metal ion bound to the β  subunit, while the
Arg side chain extends in the opposite direction to form
salt-bridge hydrogen bonds with one or two Asp residues
in the α  subunit. These two specific interactions or their
equivalent are seen both in the cRGD-α Vβ 3 structure and
in the structures of α IIbβ 3 in complex with ligand-mimet-
ics (Figure 1). There are no significant hydrophobic
"pockets" or exosites contributing to the binding specifi-
city. For example, a large fraction of the cRGD peptide
does not make any contact with the α Vβ 3 integrin surface
(Figure 1a). In the broader context of RGD-containing lig-
ands and their integrin receptors, it would seem that these
Binding of peptide ligands to the integrin surfaces Figure 1
Binding of peptide ligands to the integrin surfaces. (a) Detail 
of the crystal structure of the extracellular region of α Vβ 3 
integrin in complex with the cyclic pentapeptide Arg-Gly-
Asp-D-Phe-N(Me)-Val [8]. The peptide (orange), sits across 
the interface between the α V (red) and β 3 (green) integrin 
subunits, but only the three amino acids from the RGD triad 
make significant contact with the integrin surface. The Asp 
residue completes the coordination of one of the three Mn2+ 
ions (purple spheres) at the top of the β 3 subunit. (b) Detail 
of the crystal structure of the extracellular region of α IIbβ 3 
integrin in complex with the cyclic peptide eptifibatide [12], 
showing very similar interactions. Hrg and Mpt indicate L-
homoarginine and β -mercaptopropionic acid residues, 
respectively. Due to higher resolution, water molecules 
(cyan spheres) are seen in this structure to complete the 
coordination of the metal ions. Other colours as in panel a. 
Both figures have been prepared using SETOR [45].BMC Structural Biology 2005, 5:4 http://www.biomedcentral.com/1472-6807/5/4
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interactions are mainly electrostatic and that the two
charged residues in the RGD sequence are necessary and
sufficient for attachment [14].
What about the central Gly residue? In their analysis of the
cRGD-α Vβ 3 crystal structure, Xiong et al. report that the
Gly central residue makes several hydrophobic interac-
tions with the integrin surface, including a contact with
the carbonyl oxygen of residue Arg216 in the β 3 integrin
subunit [8]. Such contact between the Gly methylene
group and a main-chain carbonyl oxygen is also observed
in the crystal structure of α IIbβ 3 in complex with the pep-
tidomimetic eptifibatide (EFB) [12] (Figure 1b), which is
a cyclic heptapeptide containing a homoArg-Gly-Asp
sequence. The particular geometry of these contacts is
strikingly reminiscent of a motif previously described in
the collagen triple helix: a hydrogen bonding arrangement
where the α -carbon of the Gly residue acts as hydrogen
bonding donor in Cα -H···O=C interactions (Figure 2)
[15].
So-called "weak" hydrogen bonds, such as those between
carbon and oxygen atoms, have been traditionally
neglected in descriptions of three-dimensional structures
of macromolecules. Yet, C-H···O hydrogen bonds are
ubiquitous in protein structures: virtually every conven-
tional N-H···O=C hydrogen bond in every β -sheet in
every determined protein structure carries a companion
Cα -H···O=C interaction [16,17]. This applies to both
parallel and antiparallel β -sheets, and exactly the same
topology is also observed in the collagen triple helix [15].
For collagen and the β -sheet structures, the occurrence of
Cα -H···O=C interactions is indicative of a very tight fit
between the molecules involved, a close-packed structure
in which all groups participate in some form of hydrogen
bonding interaction.
How important are Cα -H···O=C and other weak hydro-
gen bonds in shaping the three-dimensional structure of
proteins and macromolecular complexes? The subject has
stimulated considerable debate (see [18] and [19] for
reviews), although theoretical studies leave no doubt
about the cohesive nature of these interactions [20-23].
With a strength approximately one-half of that from con-
ventional hydrogen bonds, it seems reasonable to assume
that the large numbers of weak hydrogen bonds detected
in proteins may contribute to their stability. Furthermore,
several biochemical functions have been linked to specific
C-H···O hydrogen bonds, where position is more
important that numbers. One example is the Gly-X-X-X-
Gly motif, known to favour helix-helix interactions in
membrane [24] and soluble proteins [25]via position-spe-
cific Cα -H···O=C hydrogen bonds. Another is the pro-
posed role of C-H···O hydrogen bonds from cytosine
and thymine bases to amino acid side chains during DNA-
protein recognition [26]. Weak C-H···O hydrogen
bonds have also been surveyed at protein-protein inter-
faces [27], and have been reported to play specific roles in
catalysis [28], and in substrate and inhibitor recognition
[29-32]. Recently, a server to identify weak hydrogen
bonding interactions in protein structures has been made
publicly available [33].
The functional occurrence of weak C-H···O hydrogen
bonds in protein-ligand, protein-protein, and protein-
DNA recognition suggests that their presence should be
examined in detail in the structures of macromolecules
with biomedical or biotechnological interest. Their poten-
tial should not be neglected in rational drug design
approaches [31]. With this in mind, we present here an
analysis of possible Gly-Cα -H···O=C interactions
between RGD motifs and the RGD-binding sites from the
α Vβ 3 and α IIbβ 3 crystal structures. We conclude that the
mutual geometry of the interaction is consistent with Cα -
H···O=C hydrogen bonding. We discuss the implica-
tions of these hydrogen bonds for the cell adhesion inter-
actions between integrins and their RGD-containing
ligands.
Results and discussion
Building standard-geometry Hα  atoms on the Gly central
residues of the cRGD and EFB peptides produces the geo-
metric arrangements shown in Figure 2, clearly reminis-
cent of the hydrogen bonding pattern previously
described in the collagen triple helix (Figure 2c). The met-
rics of these Gly-carbonyl contacts are shown in Table 1.
The Cα ···O distances in the cRGD-α Vβ 3 and EFB-α IIbβ 3
structures appear to be longer than the mean Cα ···O dis-
tance in collagen, but are well within the observed range
in crystal structures of small organic molecules (see
below). Both Hα  atoms from the collagen Gly residues are
in hydrogen bonding position (Cα –Hα ···O > 90°), and
their Cα -Hα ···O=C hydrogen bonds adopt a three-cen-
tred and bifurcated configuration (Figure 2c and [15]),
that is not seen in the integrin structures. Nevertheless, the
central Gly residues in the cRGD and EFB peptides appear
to have one and two Hα  atoms respectively in hydrogen
bonding position to the carbonyl group of Arg216, a resi-
due on the surface of the β 3 subunit and directly at the
interface with the α V and α IIb subunits.
An obvious caveat to this analysis comes from the moder-
ate resolution of the cRGD-α Vβ 3 and EFB-α IIbβ 3 crystal
structures (3.2 Å and 2.9 Å respectively). Positional errors
inevitable at that resolution may affect the precision of the
fitting of the cRGD and EFB peptides and the accuracy of
the hydrogen bonding geometries for both weak and
strong hydrogen bonds. For example, a close look at the
salt-bridge interactions between the Arg guanidinium
group from the cRGD peptide and two Asp side chains onBMC Structural Biology 2005, 5:4 http://www.biomedcentral.com/1472-6807/5/4
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Geometry of Gly-Cα ···O=C interactions after Gly α -hydrogen atoms are placed in their stereochemically predicted positions  for: (a) the cRGD-α Vβ 3 crystal structure, and (b) the EFB-α IIbβ 3 crystal structure Figure 2
Geometry of Gly-Cα ···O=C interactions after Gly α -hydrogen atoms are placed in their stereochemically predicted positions 
for: (a) the cRGD-α Vβ 3 crystal structure, and (b) the EFB-α IIbβ 3 crystal structure. Atoms are colour coded as follows: oxy-
gen, red; nitrogen, blue; hydrogen, white; metal, purple; carbon from integrin in grey; and carbon from the cRGD and EFB pep-
tides in orange. Cα -H···O hydrogen bonds are shown as green dashed lines. (c) Hydrogen bonding in the collagen triple helix 
[15]. Conventional hydrogen bonds are shown in yellow, Cα -H···O hydrogen bonds in green. The two Hα  atoms in collagen 
Gly residues participate in a bifurcated and three-centred hydrogen bonding configuration. Naming of Gly-Hα  atoms follows 
the convention that Hα 1 is equivalent to Hα  in L-amino acids.BMC Structural Biology 2005, 5:4 http://www.biomedcentral.com/1472-6807/5/4
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the α V integrin surface (Asp150 and Asp218), shows less
than "ideal" hydrogen bonding orientation, especially for
Asp150 (not shown). Yet, the accumulated knowledge of
hydrogen bonding geometries in high-resolution crystal
structures and their significant variability leaves no doubt
about the existence of these strong hydrogen bonds and
their contribution to the specificity of binding.
A similar level of confidence can be achieved for the Gly-
Cα -Hα ···O=C hydrogen bond by analysing the metrics
of equivalent interactions in high-resolution crystal struc-
tures of small organic and organometallic molecules. Fig-
ure 3 shows the two fragment probes used in a statistical
search for Gly-Cα -Hα ···O=C nonbonded interactions in
the Cambridge Structural Database (see Methods). Figure
4 shows that single hydrogen bonding (only one angle
Cα -Hα ···O  ≥  90°) predominates over the bifurcated
case, and that a broad maximum in the Cα ···O distribu-
tion occurs at about 3.4 Å, which can be taken as the
"hydrogen bonding distance" for this type of interaction.
This value is consistent with the theoretical value of 3.34
Å for the Gly-Cα -Hα ···OH2 hydrogen bond from ab ini-
tio quantum calculations [22]. Figure 5 shows the distri-
butions of Hα ···O distances and Cα -Hα ···O angles for
the single hydrogen bond. The Hα ···O distribution
shows a broad maximum around 2.7 Å, whereas the
angular distribution is very broad with maxima around
110° and 140°. Average parameters for single and double
Gly-Cα -Hα ···O=C hydrogen bonding (Table 1) are per-
fectly compatible with those calculated for the cRGD-
α Vβ 3 and EFB-α IIbβ 3 structures respectively, even though
the accuracy of the values shown in Table 1 is clearly over-
estimated with respect to the resolution of these crystal
structures. Thus, strictly from a geometrical point of view,
the contacts between the Gly residues in the cRGD and
EFB peptides and the main chain carbonyl group from
Arg216 in the integrin surface bear all the characteristics of
Cα -Hα ···O=C hydrogen bonding. This observation is
consistent with the exceptionally high frequency of inter-
molecular Gly-Cα -H···O=C hydrogen bonds recently
reported in high resolution crystal structures of protein-
ligand complexes [32].
A simple molecular docking analysis further supports the
occurrence of Gly-Cα -H···O=C hydrogen bonds
between RGD-containing ligands and integrin binding
sites. In a first set of calculations, an RGD tripeptide was
docked into the binding sites of both α Vβ 3 and α IIbβ 3
integrins using constrained molecular dynamics (MD).
Two constraints were imposed in the docking calcula-
tions: the carboxyl group from the Asp residue had to
complete the metal coordination on the β 3 subunit, and
the Arg side chain had to form a salt bridge with appropri-
ate Asp residues in the α V and α IIb subunits (see Meth-
ods), as observed in the crystal structures of α Vβ 3 and
α IIbβ 3 with different ligand-mimetics. Ten slightly differ-
ent RGD models were obtained from the NMR structures
of the adhesion domain of fibronectin [34], and were
placed about 10 Å away from the integrin surface. Then
these RGD models were subject to MD simulations until
they docked into the integrin binding sites. In a second set
of calculations, a longer peptide fragment with sequence
Table 1: Interatomic distances and angles for proposed and observed Gly-Cα -Hα ···O hydrogen bonding interactions.
PDB structures * CSD Average values †
1L5Ga 1TY6b 1CGDc CH2···O H-CH···O
distances (Å)
Cα ···O 3.39 3.48 3.15 3.45 (0.19) 3.44 (0.20)
Hα 1···O 3.28 3.22 2.79 3.06 (0.25) 3.94 (0.38)
Hα 2···O 2.68 2.99 2.63 3.05 (0.23) 2.81 (0.31)
angles (°)
Cα –Hα 1···O 86 94 100 106 (11) 50 (23)
Cα –Hα 2···O 121 108 109 107 (11) 127 (23)
Hα 1···O=C 136 139 110 118 (26) 119 (26)
Hα 2···O=C 150 168 91 115 (27) 119 (24)
* Distances and angles measured on each structural model after standard-geometry Hα  building on the central Gly residues. The accuracy of 
distances and angles in the integrin structural models is probably overestimated, due to the resolution of these structural determinations.
† Average values for instances of double (CH2···O) and single (H-CH···O) Gly-Cα -H···O hydrogen bonding in the Cambridge Structural Database 
(July 2003 release). Standard deviations in parentheses. See Methods and Figures 3, 4 and 5 for details of the search. In the single hydrogen bond 
case, column Hα  1 refers to the atom in hydrogen bonding position (Cα -Hα 1···O ≥  90°) and Hα  2 to the atom in non-bonding position (Cα -
Hα 2···O < 90°).
a RGD-α Vβ 3 crystal structure, PDB accession code 1L5G [8].
b EFB-α IIbβ 3 crystal structure, PDB accession code 1TY6 [12].
c Average values from the crystal structure of the collagen-like peptide (Pro-Hyp-Gly)4-Pro-Hyp-Ala-(Pro-Hyp-Gly)5, PDB accession code 1CGD 
[15].BMC Structural Biology 2005, 5:4 http://www.biomedcentral.com/1472-6807/5/4
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VTGRGDSPAS from the adhesion domain of fibronectin
was also docked into the binding sites of the two integrins
(Figure 6). Again, ten different models for this peptide
were obtained from fibronectin NMR structures [34].
Most of the simulations converged to models with
Cα ···O contact distances between the central Gly resi-
due and the carbonyl of Arg216 in the 2.7–3.7 Å range
(Figure 6b), with either one or two Gly-Hα  atoms in
hydrogen bonding orientation. These models were also
the most favourable energetically (Table 2). From these
calculations it seems to emerge that the RGD binding sites
of the α Vβ 3 and α IIbβ 3 integrins are primed to place the
central Gly residue in the RGD triad directly above the car-
bonyl group of Arg216 of the β 3 subunit (as observed in
the cRGD-α Vβ 3 and EFB-α IIbβ 3 crystal structures), form-
ing one or two Cα -H···O hydrogen bonds that comple-
ment the main metal-coordination and salt-bridge
interactions from the Asp and Arg side chains.
How important are these weak C-H···O hydrogen bonds
in stabilising the cRGD-α Vβ 3 and EFB-α IIbβ 3 complexes?
A quantitative analysis of C-H···O hydrogen bonding at
protein-protein interfaces has shown that they have an
important contribution to the association and stability of
protein complexes, accounting for about one third of the
total hydrogen bonding interaction energy [27]. In fact,
some of the hydrophobic or van der Waals interactions
usually invoked to explain stabilising close contacts
between molecules can be described better as weak C-
H···O hydrogen bonds. These occupy a middle ground
between the highly directional, conventional hydrogen
bonds, and the directionless van der Waals interactions
[32].
The recurrent appearance of some weak hydrogen bond-
ing topologies in many structures of proteins and at pro-
tein-protein interfaces also reinforces the notion that they
have a significant contribution to macromolecular stabil-
ity. The most common occurrence of C-H···O hydrogen
bonds in protein structures is a widespread Cα -H···O=C
hydrogen bond N-terminal to the conventional N-
H···O=C hydrogen bond in β -sheets [16,17] and in the
collagen triple helix [15]. In this structural motif (Figure
7a), the Cα -H donor group is in the residue immediately
N-terminal to the one carrying the N-H donor group, and
both share the same C = O group as acceptor, an arrange-
ment sometimes referred as "bifurcated" hydrogen bond
[17,18,27]. This bifurcated hydrogen bonding motif is
also the most common occurrence of C-H···O hydrogen
bond at protein-protein interfaces [27]. The situation in
Figure 7b occurs when the residue N-terminal to the one
carrying the N-H donor group is Gly, with one or two Hα
from Gly being in hydrogen bonding position. The
bifurcated hydrogen bond scenario also occurs in the
cRGD-α Vβ 3 and EFB-α IIbβ 3 structures, where the N-H
group from the Asp residue in the RGD peptide donates a
hydrogen bond to the main chain carbonyl group from
Fragments used in searches for non-bonded interactions in  the Cambridge Structural Database [44] Figure 3
Fragments used in searches for non-bonded interactions in 
the Cambridge Structural Database [44]. Å 3.8 Å Cα ···O dis-
tance cutoff was applied in all searches. A hydrogen atom 
was deemed to be in hydrogen bonding position if the angle 
Cα -H···O ≥  90°. Separate searches were conducted for the 
bifurcated hydrogen bond (both angles ≥  90°), single Cα -
H···O=C hydrogen bond (one angle ≥  90°, the other < 90°) 
and no hydrogen bonds (both angles < 90°).BMC Structural Biology 2005, 5:4 http://www.biomedcentral.com/1472-6807/5/4
Page 7 of 13
(page number not for citation purposes)
Distribution of Cα ···O distances in the Cambridge Structural Database structures (July 2003 release), containing the motif  depicted in Figure 2 Figure 4
Distribution of Cα ···O distances in the Cambridge Structural Database structures (July 2003 release), containing the motif 
depicted in Figure 2. Three cases are considered: single Cα -H···O hydrogen bond (light grey), bifurcated hydrogen bond (dark 
grey), and no hydrogen bond (white). The single hydrogen bonded case clearly dominates with 1688 hits overall, for 218 of the 
bifurcated case and 166 hits for the no hydrogen bond case. The maximum in the single hydrogen bond distribution around 3.4 
Å suggests that value as the Cα ···O hydrogen bonding distance, although a significantly large number of interactions can be still 
classified as hydrogen bonds at the longer Cα ···O distances.BMC Structural Biology 2005, 5:4 http://www.biomedcentral.com/1472-6807/5/4
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Distribution of H···O distances (a) and Cα -H···O angles (b) for the 1688 instances of single Gly-Cα -H···O hydrogen bonding  in crystal structures of the Cambridge Structural Database (July 2003 release) Figure 5
Distribution of H···O distances (a) and Cα -H···O angles (b) for the 1688 instances of single Gly-Cα -H···O hydrogen bonding 
in crystal structures of the Cambridge Structural Database (July 2003 release).BMC Structural Biology 2005, 5:4 http://www.biomedcentral.com/1472-6807/5/4
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Results of molecular dynamics simulations of docking fibronectin RGD-containing peptides on to models of integrin surfaces Figure 6
Results of molecular dynamics simulations of docking fibronectin RGD-containing peptides on to models of integrin surfaces. 
(a) Representation of the 15 lowest-energy models for the docking of the VTGRGDSPAS peptide on α IIbβ 3 model surface. 
Integrin residues are shown in black whereas the 15 peptide models are shown in different colours. For peptide models, the 
only side chains shown are those from the RGD triad (indicated with red labels). In all models the central Gly residue in the 
RGD triad is located directly on top of the carbonyl group from Arg 216 in the β 3 subunit (shown with blue label). (b) Distri-
bution of Cα ···O distances in the final models of the molecular dynamics simulations Distances computed between the carbo-
nyl oxygen in Arg216 from the β 3 subunit and the central Gly residue from the RGD triad.BMC Structural Biology 2005, 5:4 http://www.biomedcentral.com/1472-6807/5/4
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Arg216 of β 3. This hydrogen bond has very bad geometry
in the cRGD-α Vβ 3 structure (distance H···O 2.69 Å,
angle N-H···O 133°), but looks better in the EFB-α IIbβ 3
structure (distance H···O 2.39 Å, angle N-H···O 144°).
These deviations from ideal hydrogen bonding geometry
might be consequence of the resolution of the crystal
structures, but all the MD docking simulations described
above result in N-H···O=C hydrogen bonds that are
slightly longer (typical H···O distances 2.4–2.5 Å) and
slightly less linear (typical N-H···O angles 140°-150°)
than the average hydrogen bonds between peptide groups
in protein secondary structures. Automatic computational
docking calculations of known integrin ligands on struc-
tural models of α Vβ 3 and α Vβ 5 consistently predict this
N-H···O=C hydrogen bond to occur whenever an N-H
group is present in the proximity of the carboxylate moi-
Table 2: Gly-Cα -H···O=C contact distances (Å) for the lowest-energy model in each set of molecular docking simulations. Underlined 
distances correspond to Hα  atoms in hydrogen bonding orientation (angle Cα -H···O=C > 90°).
Cα ···O Hα  1···O Hα 2···O
RGD-α Vβ 3 3.23 2.19 3.90
RGD-α IIbβ 3 3.21 4.03 2.29
VTGRGDSPAS-α Vβ 3 3.31 2.96 2.73
VTGRGDSPAS-α IIbβ 3 3.00 2.51 2.66
Bifurcated hydrogen bonding topologies Figure 7
Bifurcated hydrogen bonding topologies. (a) The ubiquitous bifurcated hydrogen bonding topology seen in β -sheets and also in 
the collagen triple helix. The peptide chain is depicted with the N-terminus to the left. (b) Variation of the same bifurcated 
topology when the residue N-terminal to the donor N-H group is Gly, as observed in the cRGD-α Vβ 3 and EFB-α IIbβ 3 crystal 
structures when Gly Hα  atoms are built with standard geometry. Either one or two of the Gly Hα  atoms can be in hydrogen 
bonding position. (c) Variation of the same bifurcated topology when the CH2 group N-terminal to the donor N-H group is 
replaced by another N-H group. This situation occurs for example when Gly is substituted by aza-glycine [37].BMC Structural Biology 2005, 5:4 http://www.biomedcentral.com/1472-6807/5/4
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ety [35,36]. Had these simulations included all nonpolar
hydrogens, the companion Cα -H···O=C hydrogen
bonds from the Gly residues would also have been
observed.
A quick inventory of hydrophobic interactions between
the cRGD and EFB peptides and the α Vβ 3 and α IIbβ 3 sur-
faces suggests an additional candidate for classification as
C-H···O=C hydrogen bond, between the Cβ -Hβ  group
from the Asp residue of the cRGD and EFB peptides and
the main chain C = O group from Asn215 in the β 3 subu-
nit. This weak hydrogen bond is adjacent to the stronger,
conventional hydrogen bond between the main chain N-
H group from Asn215 and Oδ 2 from the Asp residue in
the RGD motif. Thus, a total of four hydrogen bonds,
weak and conventional, aligns the bottom of the cRGD
and EFB peptides against the integrin surfaces (Figure 8),
and complements the main interactions from the Asp car-
boxyl and Arg guanidinium groups to provide a higher
binding specificity.
It is clear from the cRGD-α Vβ 3 and EFB-α IIbβ 3 structures
that any side chain other than Gly in the RGD triad would
not allow it to fit snugly within the integrin binding site,
with the resulting weakening of hydrogen bonding and
van der Waals interactions. Furthermore the main chain
conformation for the central Gly residue in the cRGD-
α Vβ 3 structure falls in a region of the Ramachandran map
that is not allowed to any L-amino acid residue. Thus, Gly
residues at the centre of the RGD motif are essential for
being small, for being able to adopt specific main chain
conformations, and for being able to interact closely with
the integrin surface via Cα -H···O=C hydrogen bonds.
All three characteristics contribute to the integrin-binding
specificity of Gly residues at the centre of RGD motifs.
Inasmuch as the cRGD-α Vβ 3 and EFB-α IIbβ 3 structures
remain valid models for the structural basis of integrin-
RGD ligand-binding specificity, it is reasonable to assume
that the weak Cα /β -H···O=C hydrogen bonds depicted
in Figure 8 will also occur in RGD-based cell-adhesion
interactions. A special feature of the integrin surface at the
RGD-binding site is the presence of two main chain carb-
onyl groups exposed to the solvent in the β 3 subunit:
Asn215 and Arg216. In absence of ligands these groups
will probably interact with water molecules through con-
ventional hydrogen bonding interactions (as seen for
example in the crystal structure of the cacodylate-bound
form of α IIbβ 3, PDB accession code 1TXV [12]). Upon lig-
and binding, the RGD residues will displace these waters
and place one amide and two methylene groups in hydro-
gen bonding position to carbonyl groups, increasing the
specificity of the RGD-integrin interaction through
multipoint recognition (Figure 8). This strategy will obvi-
ously be exploited by many competitive inhibitors for the
integrin RGD-binding site. For example it is possible to
substitute the weaker Cα -H donors from the Gly residue
by a conventional N-H group (Figure 7c). This strategy has
been exploited already in the design of aza-peptide and
azacarba-peptide RGD mimetics [37-39], several of them
with nanomolar activity. Molecular modelling of the
interaction of these peptides with α Vβ 3 and α Vβ 5 RGD
binding sites predicts the hydrogen bonding topology
shown in Figure 7c[36]. It is interesting to notice that even
in the absence of a conventional hydrogen bonding
donor, the carbonyl group Arg216 in the β 3 subunit still
may be acceptor for weak hydrogen bonds. In the crystal
structure of α IIbβ 3 in complex with tirofiban [12], a non-
peptidomimetic inhibitor derived from L-tyrosine, the
Cδ 1 atom from the substituted Tyr ring is some 3.01 Å
away from the carbonyl oxygen of the very same Arg216.
If a hydrogen atom is built with standard geometry on
Cδ 1, the calculated Hδ 1···O distance is 2.01 Å and the
Cδ 1-Hδ 1···O angle is 172°, again hydrogen bonding-
like metrics. How should this Cδ 1···O=C contact be
called? We think that a description in terms of weak C-
H···O hydrogen bonding is in this case more accurate
than referring to this interaction as simply hydrophobic.
An array of four hydrogen bonds, two N-H···O=C (in yel- low) and two C-H···O=C (in green), line up the bottom of  the cRGD peptide against the integrin surface Figure 8
An array of four hydrogen bonds, two N-H···O=C (in yel-
low) and two C-H···O=C (in green), line up the bottom of 
the cRGD peptide against the integrin surface. The two weak 
Cα /β -H···O=C interactions thus contribute to the specificity 
of binding and presumably also have a cooperative effect on 
stability. Colour scheme for atom types as in Figure 2.BMC Structural Biology 2005, 5:4 http://www.biomedcentral.com/1472-6807/5/4
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Conclusions
We have analysed in detail recently published structural
data on the interaction between the extracellular regions
of two integrins and peptides containing or mimicking
the RGD sequence [8,12]. From this analysis we conclude
that Cα -H···O=C hydrogen bonds from the central Gly
residue also contribute to the specificity of binding. Weak
hydrogen bonds are traditionally overlooked when
describing protein structures, although they probably
contribute to their stability. We think that our analysis
provides one of the most interesting examples of C-
H···O hydrogen bonds playing an important biological
role, and may contribute to reverse the current trend of
neglect of these interactions. In a recent paper, Sarkhel
and Desiraju suggest that Nature may take advantage of
the weaker C-H···O hydrogen bonds to optimise the
efficiency of protein-ligand interactions, with a larger
number of interactions coming into play even at the
expense of the strength of the individual interactions [32].
By using more interactions, they suggest, specificity of rec-
ognition is increased, and because individual interactions
are weaker, reversibility is possible. Our analysis of the
interaction between the cRGD and EFB peptides and the
α Vβ 3 and α IIbβ 3 integrin surfaces would seem to corrob-
orate this suggestion.
Methods
Integrin binding sites and hydrogen building
The following crystal structure coordinates were down-
loaded from the Protein Data Bank [40]: α Vβ 3 integrin in
complex with a cyclic RGD peptide (cRGD), PDB
accession code 1L5G [8]; α IIbβ 3 integrin structure at 2.7
Å resolution, PDB accession code 1TXV [12]; α IIbβ 3 in
complex with eptifibatide (EFB), PDB accession code
1TY6 [12]; α IIbβ 3 in complex with tirofiban, PDB acces-
sion code 1TY5. Models for integrin RGD-binding sites on
α Vβ 3 and α IIbβ 3 were obtained by selecting coordinates
from integrin residues within 10 Å from the bound pep-
tides. For the α IIbβ 3 binding site, coordinates of the cor-
responding residues in the 1TXV structure were used, as
this crystal structure has a better resolution. Coordinates
for metal ions and structural waters present in the RGD-
binding sites but not interfering with the binding of cRGD
or EFB were also maintained. Hydrogen atoms were built
with standard stereochemistry for the cRGD and EFB pep-
tides and for the integrin RGD-binding sites as defined
above, using the program REDUCE [41]. For the purpose
of the analysis presented here all hydrogen atoms dis-
cussed in this paper could be positioned with satisfactory
accuracy and predictable orientation.
Molecular docking calculations
For the molecular docking calculations, conformational
models for RGD and VTGRGDSPAS peptides were
obtained from the NMR structures of the adhesion
domain in fibronectin [34]. Ten conformational models
were used for each peptide. Each model was first manually
docked approximately into the coordinates of the binding
sites of α Vβ 3 and α IIbβ 3 integrins, using the cRGD-α Vβ 3
and EFB-α IIbβ 3 structures for guidance. Then each
docked model was pulled away to about 10 Å from the
integrin surfaces, and was docked back into the integrin
binding site via molecular dynamics (MD) simulations
using the program CNS [42]. Five simulations were run
for each model, to a total of 50 MD simulations for each
peptide-integrin pairing. A set of distance restraints was
applied to the docking MD simulations, as observed on
the cRGD-α Vβ 3 and EFB-α IIbβ 3 structures. The side chain
of the Asp residue group was restrained to coordinate the
bound metal ion in the RGD-binding sites and to receive
a hydrogen bond from the amide group of Asn215, in the
β 3 subunit. The side chain of the Arg residue was
restrained to form hydrogen bonds with residues Asp150
and Asp218 on the α V subunit or residue Asp224 on the
α IIb subunit. Additional restraints were imposed in the
MD simulations with the VTGRGDSPAS peptide: the ring
of Pro172 was restrained to hydrophobic contact with the
side chain of Lys125, in the β 3 subunit, and the Cα  atoms
of the N- and C-terminal residues in the peptide model
were restrained not to separate more than 5 Å from each
other. The coordinates of the integrin binding sites were
kept fixed in all the simulations, and only the peptides
were allowed to refine by restrained MD and energy min-
imisation. All molecular models were analysed with the
program CHAIN [43] in a Silicon Graphics workstation.
Analysis of hydrogen bonding geometry in crystal 
structures of organic molecules
A survey in the Cambridge Structural Database [44] (July
2003 release), was carried out for Cα ···O contacts
between glycine-like fragments and carbonyl groups (Fig-
ure 3).
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